These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 989140)

  • 1. Editorial: Much hope but little proof.
    Danilevicius Z
    JAMA; 1976 Oct; 236(14):1613. PubMed ID: 989140
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of acute exertion and physical training on platelet function of the coronary patient].
    Broustet JP; Boisseau M; Bouloumie J; Emeriau JP; Bricaud H
    Arch Mal Coeur Vaiss; 1976 Mar; 69(3):305-13. PubMed ID: 828016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin enhances platelet aggregation induced by adenosine diphosphate in vitro.
    Wu Q; Huang KS; Chen M; Huang DJ
    Platelets; 2009 Sep; 20(6):428-31. PubMed ID: 19639515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
    Mehta J
    JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
    Terres W; Schuster O; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
    Smout J; Cleanthis M; Stansby G
    Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Platelet aggregation.
    Vaisrub S
    JAMA; 1975 Oct; 234(4):417. PubMed ID: 1174378
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account.
    Tantry US; Mahla E; Gesheff MG; Gurbel PA
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1547-56. PubMed ID: 24147519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation studies in coronary artery disease. Past 4. Effect of aspirin.
    Mehta J; Mehta P; Burger C; Pepine CJ
    Atherosclerosis; 1978 Oct; 31(2):169-75. PubMed ID: 728235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin-like defect - a hereditary thrombocytopathy due to impaired release of platelet adenosine diphosphate].
    Elezović I; Mijović A; Rolović Z
    Bilt Hematol Transfuz; 1979; 7(2-3):165-74. PubMed ID: 263623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
    Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
    J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of erythrocytes in the pathogenesis of functional disorders of blood platelets in patients with ischemic heart disease and the possibilities of their pharmacological correction].
    Leonova MV; Razumov VB
    Kardiologiia; 1990 Apr; 30(4):107-11. PubMed ID: 2203926
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet function in blood from the coronary sinus in patients with arteriosclerotic heart disease.
    Thaulow E
    Thromb Haemost; 1983 Oct; 50(3):629-32. PubMed ID: 6228029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the platelets.
    Born GV
    Z Kardiol; 1984; 73 Suppl 2():29-31. PubMed ID: 6528701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.